Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_ENERCOLNONINF,Inverse variance weighted,35,1.08 [1.03-1.12],0.000363486865620975,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,Inverse variance weighted,30,1.06 [1.02-1.09],0.000420811663118178,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Wald ratio,1,1.3 [1.12-1.51],0.000502343245803099,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,Wald ratio,1,1.2 [1.08-1.32],0.000502343245803099,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_FIBROCHIRLIV,Inverse variance weighted,2,1.06 [1.03-1.1],0.000504195797350744,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter II Neoplasms,C3_BILIARY_GALLBLADDER_EXALLC,Inverse variance weighted,3,1.06 [1.02-1.09],0.00110041792759405,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_VARICVEOES,Inverse variance weighted,2,1.05 [1.02-1.07],0.00146836621673407,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_DISLIVOTH,Inverse variance weighted,3,1.09 [1.03-1.14],0.00151493328705525,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_BLOOD_IMMUN,Wald ratio,1,1.61 [1.19-2.19],0.00220335803569975,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,NAFLD,Inverse variance weighted,6,1.04 [1.01-1.07],0.00377806373781174,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_RHEUMA,Inverse variance weighted,22,1.09 [1.02-1.17],0.0144224444551866,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Wald ratio,1,1.09 [1.02-1.18],0.0149722739006548,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,Inverse variance weighted,36,1.07 [1.01-1.12],0.0152323534547587,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,IPF,Inverse variance weighted,20,1.02 [1-1.03],0.0165651363020486,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,COPD_EARLY,Inverse variance weighted,3,1.07 [1.01-1.13],0.018614987248339,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_SARCOIDOSIS,Inverse variance weighted,7,1.07 [1.01-1.14],0.0214977144392327,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERANAEMIA,Wald ratio,1,1.26 [1.02-1.55],0.031117057557195,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_ATHSCLE,Inverse variance weighted,13,1.06 [1-1.12],0.0327343050761845,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,ILD,Inverse variance weighted,21,1.02 [1-1.04],0.0350346998859756,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_EMPHYSEMA,Wald ratio,1,1.05 [1-1.11],0.0478366996358731,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_LOWCHRON,Inverse variance weighted,61,1.05 [1-1.11],0.0612135725754508,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,Inverse variance weighted,4,1.09 [1-1.18],0.0620703386680555,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,N14_URINOTH,Inverse variance weighted,2,0.84 [0.69-1.01],0.064586609460046,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,COPD_LATER,Wald ratio,1,1.08 [1-1.17],0.064594585356774,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_SEQULAE,Inverse variance weighted,4,1.08 [0.99-1.18],0.0705667807529661,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,AUD,Inverse variance weighted,6,1.04 [1-1.09],0.077687348638568,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_IMPLICIT,Wald ratio,1,1.24 [0.98-1.58],0.0781372046058491,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_OTHDIG,Inverse variance weighted,12,0.94 [0.87-1.01],0.081020917754516,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,Inverse variance weighted,3,1.05 [0.99-1.11],0.0844861785124173,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,COPD_HOSPITAL_MAIN,Inverse variance weighted,7,1.06 [0.99-1.13],0.0859190497251459,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,8,1.05 [0.99-1.12],0.0893100484989254,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_ALCOLIV,Inverse variance weighted,4,1.04 [0.99-1.1],0.102626597203517,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,F5_ALCOHOL_DEPENDENCE,Inverse variance weighted,3,1.04 [0.99-1.08],0.126256213243584,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_OTHENTERCOL,Inverse variance weighted,2,1.09 [0.98-1.21],0.126575675126944,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter II Neoplasms,C3_LUNG_NONSMALL_EXALLC,Inverse variance weighted,6,1.04 [0.99-1.08],0.132442647077099,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H8_OTHEREAR,Inverse variance weighted,18,0.94 [0.87-1.02],0.135220305223201,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_ACUTELOWERNAS,Wald ratio,1,0.92 [0.82-1.03],0.140745867452482,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,L12_INFECT_SKIN,Wald ratio,1,1.23 [0.93-1.62],0.143545889858673,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_LOWERINF,Wald ratio,1,0.84 [0.66-1.06],0.144196653906983,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_ASTHMA_EXMORE,Inverse variance weighted,59,1.03 [0.99-1.08],0.152881641149405,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_RESPIRATORY,Inverse variance weighted,15,1.06 [0.97-1.17],0.173759497221808,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,2,1.03 [0.99-1.08],0.190260723643755,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,16,1.07 [0.96-1.2],0.209226042313032,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter VI Diseases of the nervous system,G6_EPIPAROX,Inverse variance weighted,11,1.16 [0.92-1.47],0.213421401833479,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,Wald ratio,1,1.03 [0.98-1.09],0.221100255731358,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_BACTINF_NOS,Inverse variance weighted,2,0.92 [0.79-1.06],0.239921110628218,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_OESSTODUO,Wald ratio,1,1.27 [0.85-1.9],0.244523562446641,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Wald ratio,1,0.85 [0.64-1.14],0.284424416563632,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_INTESTOTH,Inverse variance weighted,10,1.09 [0.93-1.29],0.287562817155625,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_OTHFUNC,Wald ratio,1,0.89 [0.71-1.11],0.297706091130138,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Wald ratio,1,1.1 [0.92-1.31],0.304057737866619,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Inverse variance weighted,69,0.99 [0.96-1.01],0.304860115241824,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_LBBB,Inverse variance weighted,2,1.03 [0.98-1.08],0.311140571756532,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,7,1.04 [0.97-1.11],0.317794611868139,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Wald ratio,1,0.89 [0.71-1.12],0.323979319774609,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,ASTHMA_NAS,Inverse variance weighted,13,0.96 [0.89-1.04],0.330874887864926,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_CONDITION,Wald ratio,1,0.87 [0.64-1.19],0.384173169361069,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,2,1.06 [0.93-1.2],0.396747190072642,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,ALCOHOLMENTAL,Wald ratio,1,0.96 [0.85-1.08],0.465646495245749,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,F5_DEPRESSION_DYSTHYMIA,Inverse variance weighted,24,1.03 [0.95-1.11],0.466153441045663,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHYOTH,Inverse variance weighted,27,1.03 [0.95-1.13],0.470598233719679,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Wald ratio,1,1.03 [0.95-1.11],0.471271307224727,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_PAD,Inverse variance weighted,2,1.03 [0.95-1.12],0.496989342516799,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Wald ratio,1,1.01 [0.98-1.04],0.510917273735275,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,SMOKING_DEPEND,Wald ratio,1,0.97 [0.9-1.06],0.530135122893948,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,Inverse variance weighted,11,1.02 [0.96-1.08],0.531373014275867,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_COELIAC,Inverse variance weighted,52,0.99 [0.98-1.01],0.546304883677962,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,Inverse variance weighted,21,0.99 [0.95-1.03],0.559863640062916,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_LOWBACKPAIN,Inverse variance weighted,10,0.97 [0.89-1.06],0.562381223475592,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_IRON_MET,Inverse variance weighted,8,1 [0.99-1.01],0.581715305483505,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_PAROXTAC,Inverse variance weighted,7,0.99 [0.94-1.04],0.58332513063312,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_STR,Inverse variance weighted,3,0.96 [0.84-1.11],0.594592375285867,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_OTHER_WIDE,Inverse variance weighted,5,1.03 [0.9-1.18],0.639332508214413,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_PNEUMONAS,Wald ratio,1,1.05 [0.84-1.3],0.684372980219345,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter II Neoplasms,C3_BREAST_EXALLC,Inverse variance weighted,46,1 [0.97-1.02],0.688540287145,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,4,1.02 [0.91-1.15],0.710457046762989,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,COLITNONINFNAS,Wald ratio,1,0.96 [0.79-1.18],0.710633508762122,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SJOGREN,Inverse variance weighted,5,0.98 [0.9-1.07],0.725860435836862,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,3,1.06 [0.78-1.43],0.727043246390566,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,F5_DELIRIUM,Wald ratio,1,1.02 [0.9-1.15],0.728504936571665,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_CROHN,Inverse variance weighted,3,0.99 [0.96-1.03],0.729338690711968,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_AORTANEUR,Inverse variance weighted,18,0.99 [0.96-1.03],0.750372472729889,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_UAP,Inverse variance weighted,24,1.01 [0.97-1.05],0.76209727262839,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_VIRAL,Wald ratio,1,0.98 [0.85-1.13],0.765695759750988,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_CHOLELITH,Inverse variance weighted,122,1 [0.97-1.02],0.768526481154355,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,Wald ratio,1,0.95 [0.66-1.36],0.772744569127232,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_MYCOSES,Wald ratio,1,1.02 [0.86-1.22],0.785103152589794,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,Inverse variance weighted,5,0.98 [0.87-1.11],0.790538436389854,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_CD_NOUC,Inverse variance weighted,4,1 [0.97-1.02],0.795258634525271,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_GASTROENTERITIS_NOS,Inverse variance weighted,2,1.02 [0.89-1.16],0.80325481188437,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROPATHIES,Inverse variance weighted,25,1.01 [0.9-1.14],0.804616582403426,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,24,1 [0.98-1.03],0.835460484517654,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,4,0.99 [0.89-1.1],0.84128667582786,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_INTERSTITIUM,Inverse variance weighted,4,1 [0.98-1.02],0.849123728767689,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOPOROSIS,Inverse variance weighted,3,1.01 [0.9-1.14],0.85133448224319,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,4,1.02 [0.85-1.22],0.853041162771597,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter VI Diseases of the nervous system,FALLS,Inverse variance weighted,5,0.99 [0.82-1.19],0.874018077352207,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DECUBITANSULCERANDPRESSURE,Wald ratio,1,0.99 [0.93-1.06],0.877516310877966,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_CARDARR,Inverse variance weighted,2,1 [0.96-1.05],0.892344218487203,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,CHRONNAS,Inverse variance weighted,9,1 [0.97-1.02],0.897126068681425,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_GALLBILPANC,Inverse variance weighted,21,1 [0.97-1.04],0.901882760646249,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_NOS,Inverse variance weighted,6,1 [0.93-1.09],0.906165565689628,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_CONSTIPATION,Wald ratio,1,1 [0.73-1.38],0.986044912522532,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSALGIANAS,Inverse variance weighted,2,1 [0.88-1.14],0.986801854634611,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_ABAORTANEUR,Inverse variance weighted,5,1 [0.95-1.05],0.998061861809386,trans
